TH49271A - Thiazolyidine derivative as an anti-diabetic agent - Google Patents

Abstract

DC60 (05/02/44) This invention relates to a compound with the general formula (I), to its salts and possible totomer forms that are pharmaceutically recognized. This invention also describes the processes for the manufacture of such compounds and their use as antidiabetic and hypoglycemic agents, alone or in combination with other antidiabetic agents such as sulfonylurea or biguanides, as well as the treatment of complications associated with insulin resistance, such as hypertension, hyperuricemia, or other cardiovascular, metabolic, endocrine, or other diabetes-related conditions. This invention relates to a compound with the general formula (I), to its salts and possible totomer forms that are pharmaceutically recognized. This invention also describes the processes for the manufacture of such compounds and their use as antidiabetic and hypoglycemic agents, alone or in combination with other antidiabetic agents such as sulfonylurea or biguanides, as well as the treatment of complications associated with insulin resistance, such as hypertension, hyperuricemia, or other cardiovascular, metabolic, endocrine, or diabetes-related conditions. Or other conditions of the cardiovascular, metabolic, endocrine, or other conditions related to diabetes. Drug patent.

Claims (1)

1. Compounds according to the general formula (I) (chemical formula) (I), characterized by: R1 is: H or C1-C6 alkyl R2: H, C1-C6 alkyl, halogen (F , CI, Br, I), OR5, SR5, NR5R6, NO2 or phenyl R3: H, C1-C6 alkyl, halogen (F, CI, Br, I), OR5, SR5, NR5R6, NO2. Or phenyl R4: H, C1-C6 alkyl, halogen (F, CI, Br, I), OR5, NR5R6, NO2, phenyl, or R3. Tag: drug patent.